Australia’s bad drug deal
Watch an interview with Stephen Duckett
Australia’s Pharmaceutical Benefits Scheme pays at least $1.3 billion a year too much for prescription drugs. New Zealand, which has capped its budget and appointed independent experts to make decisions, pays a sixth as much as the PBS for the same drugs. This report proposes three ways Australia can regain its lost leadership in pharmaceutical pricing.